Cargando…
Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study
Intravenous (IV) iron and Erythropoiesis Stimulating Agents (ESAs) are recommended for anemia management in chronic kidney disease (CKD). This retrospective cohort study analyzed utilization patterns of IV iron and ESA in patients over 18 years of age admitted to University Health System Hospitals w...
Autores principales: | Joshi, Avani D., Holdford, David A., Brophy, Donald F., Harpe, Spencer E., Mays, Darcy, Gehr, Todd W. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345210/ https://www.ncbi.nlm.nih.gov/pubmed/22577528 http://dx.doi.org/10.1155/2012/248430 |
Ejemplares similares
-
Adverse events of iron and/or erythropoiesis-stimulating agent therapy in preoperatively anemic elective surgery patients: a systematic review
por: Laermans, Jorien, et al.
Publicado: (2022) -
THE EFFECT OF HEMOGLOBIN INJECTIONS ON ERYTHROPOIESIS AND ERYTHROCYTE SIZE IN RABBITS RENDERED ANEMIC BY BLEEDING
por: Miller, D. K., et al.
Publicado: (1934) -
Effects of hypoxia-inducible factor-prolyl hydroxylase inhibitors vs. erythropoiesis-stimulating agents on iron metabolism in non-dialysis-dependent anemic patients with CKD: A network meta-analysis
por: Yang, Junlan, et al.
Publicado: (2023) -
Mutant KLF1 in Adult Anemic Nan Mice Leads to Profound Transcriptome Changes and Disordered Erythropoiesis
por: Nébor, Danitza, et al.
Publicado: (2018) -
Iron deficiency: lessons from anemic mice.
por: Andrews, N. C.
Publicado: (1997)